An international trial involving 1,000 volunteers will aim to detect biomarkers associated with the condition.

Diagnosing Alzheimer’s, a neurodegenerative disease, is complicated and costly. A study in RI could help speed up the process ...

This article is part of “Innovations In: Alzheimer's Disease” an editorially independent special report that was produced with financial support from Eisai. The first hints that Gregory Nelson might ...

During the Jan. 28 Alzheimer's Drug Discover Foundation lecture, panelists said the tests will revolutionize diagnosis and ...

Imagine diagnosing one of the most challenging neurological diseases with just a quick finger-prick, a few drops of blood and ...

The Food and Drug Administration has given approval for a blood test that will rule out if someone has Alzheimer’s disease and other cognitive issues when they have the symptoms of the conditions. It ...

Diagnosing Alzheimer’s disease has long relied on expensive and invasive procedures, often delaying care until symptoms are well advanced. With the recent US Food and Drug Administration (FDA) ...

When I co-invented the first PET (positron emission tomography) scan to visualize brain amyloid and tau—the physical evidence of Alzheimer’s disease—I did not foresee the distressing mental impact ...

Researchers connecting pieces of the massive Alzheimer's puzzle are closer to slotting the next one in place, with yet ...

The increased size of, and lesser blood supply to, a key brain structure in patients with long COVID tracks with known blood ...